Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?-Reference-Cited by-同舟云学术

Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?

Published:2016-02-23 Issue:11 Volume:20 Page:2654-2661
ISSN:1090-7165
Container-title:AIDS and Behavior
language:en
Short-container-title:AIDS Behav

Author:

Mensch Barbara S.,Brown Elizabeth R.,Liu Karen,Marrazzo Jeanne,Chirenje Zvavahera Mike,Gomez Kailazarid,Piper Jeanna,Patterson Karen,van der Straten Ariane

Funder

National Institute of Allergy and Infectious Diseases

National Institute of Child Health and Human Development

National Institute of Mental Health

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology

Link

http://link.springer.com/content/pdf/10.1007/s10461-016-1312-2.pdf

Reference22 articles.

1. Coly A, Gorbach PM. Microbicide acceptability research: recent findings and evolution across phases of product development. Curr Opin HIV AIDS. 2008;3(5):581–6.

2. Mensch BS, van der Straten A, Katzen LL. Acceptability in microbicide and PrEP Trials: current status and a reconceptualization. Curr Opin HIV AIDS. 2012;7(6):534–41.

3. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977–87.

4. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.

5. Trussell J, Dominik R. Will microbicide trials yield unbiased estimates of microbicide efficacy? Contraception. 2005;72(6):408–13.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High adherence to intermittent and continuous use of a contraceptive vaginal ring among women in a randomized controlled trial in Kigali, Rwanda;Frontiers in Global Women's Health;2024-04-11

2. Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada;Canadian Journal of Infectious Diseases and Medical Microbiology;2022-08-30

3. Women’s experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring;AIDS and Behavior;2022-05-10

4. Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-01-01

5. The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence;AIDS and Behavior;2021-05-03